Survivin -31G/C promoter polymorphism and sporadic colorectal cancer

International Journal of Colorectal Disease

Volumn 24, Issue 2, 2009, Pages 145-150

  Gazouli, Maria ^a   Tzanakis, Nikolaos ^b   Rallis, George ^c   Theodoropoulos, George ^a   Papaconstantinou, Ioannis ^d   Kostakis, Alkiviadis ^b   Anagnou, Nicholas P ^a,e   Nikiteas, Nikolaos ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d ST MARK S HOSPITAL   (United Kingdom)

^e BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

31G C polymorphism; Colorectal cancer; Survivin

Indexed keywords

MESSENGER RNA; SURVIVIN;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER;

EID: 58549085574     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0601-2     Document Type: Article

References (21)

1. Thompson CB (1995) Apoptosis is the pathogenesis and treatment of disease. Science 267:1456-62
2. Raff M (1998) Cell suicide for beginners. Nature 396:119-22
3. Ambrosini G, Adida C, Alteri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-21
4. Deveraux QL, Reed JC (1999) IAP family proteins - suppressors of apoptosis. Genes Dev 13:239-252
5. Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584
6. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7:542-547
7. Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: There is more to life than Bcl2. Oncogene 22:8568-8580
8. Yamamoto T, Tanigawa N (2001) The role of surviving as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 34:207-212
9. Tamm I, Wang Y, Sausville E et al (1998) IAP-family protein surviving inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320
10. Asanuma K, Moriai R, Yajima T et al (2000) Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91:1204-1209
11. Velculescu VE, Madden SL, Zhang L et al (1999) Analysis of human transcriptomes. Nat Genet 4:387-388
12. Altieri DC, Marchisio PC, Marchisio C (1999) Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327-1333
13. Xu Y, Fang F, Ludewig G et al (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23:527-537
14. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal carcinoma. Cell 87:159-170
15. Sarela A, Macadam R, Farmery S, Markham A, Guillou P (2000) Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma. Gut 465:645-650
16. Kawasaki H, Altieri DC, Lu CD et al (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074
17. Borbely AA, Murvai M, Szarka K et al (2007) Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60:303-306
18. Jang JS, Kim KM, Kang KH et al (2008) Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60:31-39
19. Cheng ZJ, Hu LH, Huang SJ (2008) Correlation of -31G/C polymorphisms of surviving promoter to tumorigenesis of gastric carcinoma. Ai Zheng 27:258-263
20. Morson BC, Sobin LH (1976) Histologic typing of intestinal tumours: WHO technical report. WHO, Geneva
21. Sobin LH, Wittekind C (1997) UICC TNM classification of malignant tumours. Fifth Edition. Wiley-Liss, New York